Penn Medicine Provider
Neurology
Christopher Perrone, MD
5.0
(610)
Accepting new patients
Sees patients age 18 and up
Penn Neuroscience Center - Neurology
View 1 additional location
Make an appointmentCall 800-789-7366

About me

  • Associate Clerkship Director
  • Assistant Professor of Clinical Neurology

Education and training

  • Medical School: University of Massachusetts
  • Residency: Beth Israel Deaconess Medical Center
  • Residency: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating
5.0

611 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

April 2025
5.0
5.0
dr perrone is kind, caring, efficient, professional, highly knowledgeable
April 2025
5.0
5.0
dr. perrone is an outstanding physician. we feel very confident in his knowledge and expertise. he spends quality time with his patient. we leave every appointment with our questions answered thoroughly.
April 2025
5.0
5.0
he is professional but still has good bed side manners
April 2025
5.0
5.0
dr. perrone listens and addresses all questions. his knowledge is evident in his explanations. and he spends the time to make sure we understand.

Insurance accepted

My Locations

Learn about location
Learn about location

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Perrone is a Penn Medicine physician.

Qualifications and experience

My research

Martin ML, Robert-Fitzgerald T, Schindler MK, Perrone C, Schultz G, Lynch S, Mirkovic N, Thomas S, Elahi A, Reid D, Moore TM, Baller EB, Satterthwaite TD, Cieslak M, Covitz S, Adebimpe A, Manning A, Markowitz CE, Detre JA, Bar-Or A, Kakara M, Shinohara RT. Impact of insurance status on MRI phenotypes in MS , Mult Scler Relat Disord, 92(105919): 2024

Oh J, Smolders J, Buijs F, Meyer zu Hörste G, Perrone C, van den Brand J, Federer-Gsponer J, Pedotti R, Kaczmarek L, Sharma V, Heinzmann D, Tackenberg B, Bar-Or A, Wiendl H Defining PIRA and Lack of Disease Stability in the Real-World: Interim Results , European Committee for Treatment and Research in Multiple Sclerosis: 2024

Baller EB, Sweeney EM, Cieslak MC, Robert-Fitzgerald T, Covitz SC, Martin ML, Schindler MK, Bar-Or A, Elahi A, Larsen BS, Manning AR, Markowitz CE, Perrone CM, Rautman V, Seitz MM, Detre JA, Fox MD, Shinohara RT, Satterthwaite TD Mapping the relationship of white matter lesions to depression in multiple sclerosis , Biol Psychiatry, 95(12): 2024,1072-1080

Son JY, Hu C, McAlpine L, Bar-Or A, Dahl M, Brito SF, Kavak K, Onomichi K, Perrone C, Riley C, Song E, Walker E, Weinstock-Guttmen B, De Jager P, Longbrake E, Xia Z Post-COVID conditions in people with multiple sclerosis: A cross-sectional multicenter study , American Academy of Neurology: 2024

Riley C, Venkatesh S, Dhand A, Doshi N, Kavak K, Levit E, Perrone C, Weinstock-Guttman B, Longbrake E, MSReCOV investigators, De Jager P, Xia Z Impact of the COVID-19 pandemic on personal networks and neurological outcomes of people with multiple sclerosis: A case-control cross-sectional and longitudinal analysis , JMIR Public Health Surveill, 10(e45429): 2024

Thebault S, Yamashita L, Breville G, Espinoza D, McGoldrick T, Woodson Z, Vitone M, Gandelman S, Windle A, Kadri J, Rezk A, Kim Y, Soldan S, Perrone CM, Jacobs D, Markowitz C, Jefferson A, Schindler M, Bar-Or A Tandem CSF and blood flow-cytometric immune-cell profiling in the evaluation of neuroinflammatory conditions , Americas Committee for Treatment and Research in Multiple Sclerosis : 2024

Kim E, Lane C, McCabe K, Gandelman S, Rivera-Torres N, Kakara M, Brandstadter R, Perrone C, Schindler M, Orthmann-Murphy J, Markowitz C, Berger J, Bar-Or A, Perrone E, Noon A, Johnson D, Carmolingo A, Fuller R, Lenzi K, Lee J, Mozes J, Leibowitz L, Pileggi C, Garabedian M, Zeccardi S, Sekella N, Samudralwar R, Stein L, Price R, Jacobs D Penn multiple sclerosis and related disorders center’s approach towards addressing disparities in care in resident clinic , American Neurological Association: 2023

Baller E, Sweeney E, Bar-Or A, Cieslak M, Covitz S, Detre J, Elahi A, Manning A, Markowitz C, Martin M, Perrone C, Rautman V, Robert-Fitzgerald T, Schindler M, Siddiqi S, Thomas S, Fox M, Shinohara R, Satterthwaite T Depression as a disease of white matter network disruption: Characterizing the relationship between white matter lesions and depression in patients with multiple sclerosis , Biol Psychiatry, 93(9): 2023,S117

Venkatesh S, Riley C, Dhand A, Doshi N, Kavak K, Levit E, Perrone C, Weinstock-Guttman B, Longbrake E, De Jager P, Xia Z Impact of the COVID-19 pandemic on personal networks and neurological outcomes of people with multiple sclerosis , American Academy of Neurology, 100(17 Supplement 2): 2023,P12-3.001

Jakimovski D, Kavak KS, Longbrake EE, Levit E, Perrone CM, Bar-Or A, Benedict RHB, Riley CS, De Jager PL, Venkatesh S, Walker ELS, Xia Z, Weinstock-Guttman B Impact of resilience, social support, and personality traits in patients with neuroinflammatory diseases during the COVID-19 pandemic , Mult Scler Relat Disord , 68: 2022,104235.